Chemistry spin-out Ziylo acquired by global healthcare company in $800m deal which could transform the treatment of diabetes 17 August 2018 School of Chemistry spin-out company Ziylo has been bought by global healthcare company Novo Nordisk in a deal which could be worth around $800 million.
- Prestigious award for Bristol scientist 10 January 2019 A University of Bristol academic has been recognised for his work in the field of synthetic chemistry after being awarded the prestigious Yamada-Koga Prize 2019 from the University of Tokyo.
- £3 million for major research study into UK greenhouse gas emissions 14 December 2018 A study to develop new methods for evaluating the UK’s greenhouse gas emissions using atmospheric observations has been awarded £3M by NERC. The project, led by researchers in the School of Chemistry, is vital for assessing climate change mitigation measures.
- Carbopalladation of C-C σ-bonds enabled by strained boronate complexes 14 December 2018 Research from the Aggarwal Group reveals a new fundamental reactivity mode of palladium complexes
- Contracting Prototissues 7 December 2018 Research by Pierangelo Gobbo, Avinash J. Patil, Mei Li, Robert Harniman, Wuge H. Briscoe and Steve Mann that was recently published in Nature Materials has been highlighted on the December Issue journal cover.
- Creating rings in natural antibiotic synthesis 26 November 2018 Scientists at the University of Bristol have revealed the secrets of the key ring forming cascade in the biosynthesis of a globally used antibiotic. They hope their findings could lead to the development of antibiotics with improved properties and new biocatalysts for the clean and efficient synthesis of medicinally important molecules.
- School of Chemistry installs new LGBT+ Flagpole 20 November 2018 We are proud to announce that our new LGBT+ flagpole has been installed in the East Foyer, outside Lecture Theatre One.
- Glucose binding molecule could transform the treatment of diabetes 19 November 2018 Scientists from the School of Chemistry have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world’s first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.
- University to launch new interdisciplinary antimicrobial resistance research network 14 November 2018 Antimicrobial resistance (AMR) is an escalating global health emergency with the Organisation for Economic Co-operation and Development (OECD) estimating that 'superbugs' will kill 1.3 million people in Europe by 2050, including more than 90,000 in the UK, unless we can halt the rise in antibiotic-resistant infections. The University of Bristol is committed to tackling this global challenge and today [Wednesday 14 November] a new cross-faculty and interdisciplinary AMR research network will be launched, funded by the University's Elizabeth Blackwell Institute (EBI).
- Melanie Roffet-Salque awarded prestigious Dorothy Hodgkin Fellowship 5 November 2018 Melanie will begin her fellowship in January 2019, which will be hosted by the School of Chemistry.
- Bristol to join forces with one of the world’s most prestigious research societies 2 November 2018 The University of Bristol partners with the Max Planck Society in Germany to establish an innovative new Max Planck Centre for Minimal Biology in Bristol. The Centre will pursue game-changing research in the emerging field of minimal biology to address some of the most complex challenges in fundamental science. This could lead to transformative applications in biotechnology and medicine.